By Sheeba M. | Weedstock Market Intelligence | October 28, 2026 — 7:00 PM ET
Wednesday’s cannabis session closed with mixed signals beneath the surface. While broader equity markets held steady into the bell, cannabis names continued their Q3 earnings-season recalibration — with a handful of tickers drawing serious attention in after-hours trading. Here is what you need to know heading into Thursday.
Curaleaf (CURLF): After-Hours Volume and What It Signals
Curaleaf Holdings (OTC: CURLF) drew elevated after-hours volume Wednesday as investors continued digesting the company’s recent operational updates. Curaleaf has been navigating a prolonged restructuring cycle — trimming its footprint in underperforming markets while doubling down on core states like Florida, New York, and New Jersey, where adult-use conversion continues to widen the revenue opportunity.
Wednesday’s after-hours movement suggests institutional positioning ahead of what could be a meaningful Q3 update. Curaleaf has not yet confirmed its earnings date, but analysts widely expect a late-October or early-November report. With the company having previously guided toward adjusted EBITDA improvement in the back half of 2026, the tape is watching closely for any pre-announcement signals.
Traders tracking CURLF should note that thin OTC liquidity can amplify after-hours moves in either direction. Confirmation of a defined earnings date would likely prompt fresh positioning across the MSO peer group. Keep this one on your radar; the risk/reward setup going into any earnings catalyst is asymmetric enough to warrant attention.
Tilray Brands (TLRY): Fiscal Q1 FY2027 Report on Deck
Tilray Brands (Nasdaq: TLRY) is approaching its fiscal Q1 FY2027 reporting window, and the market is threading a needle between two very different narratives. On one side, Tilray’s U.S. beer and beverage brands — including SweetWater Brewing, Montauk Brewing, and the recently acquired craft portfolio — have provided a differentiated revenue base that pure-play cannabis LPs cannot match. On the other side, the Canadian cannabis business continues to face margin compression from persistent oversupply in the domestic market.
Thursday’s trading session will be closely watched for any pre-earnings analyst commentary. Tilray’s management has consistently emphasized optionality: if federal reform in the United States advances, TLRY’s existing U.S. infrastructure and brand recognition position it as one of the few Canadian LPs genuinely capable of pivoting into the American market at scale. That thesis has kept a floor under TLRY even as peers have struggled.
Key metrics to watch in the upcoming report: gross margin trajectory on the beverage division, Canadian wholesale volume trends, and any updated guidance on the path to sustained profitability. TLRY trades with high retail participation, meaning earnings-week volatility can be sharp and swift in both directions.
Broader Market Color: Q3 Earnings Season in the Rearview
With Green Thumb Industries (GTBIF), Canopy Growth (CGC), and Aurora Cannabis (ACB) all having released or previewed Q3 data points this week, the picture for the cannabis sector in Q3 2026 is coming into focus. The common thread: companies with disciplined cost structures and exposure to adult-use state conversions are outperforming. Companies still dependent on Canadian recreational or legacy markets without a clear U.S. pathway are facing pressure.
Illinois continues to generate outsized discussion — the state’s cultivation cap and license structure remain a source of competitive advantage for operators with early-mover positions. Investors watching the MSO space should monitor Illinois-heavy operators heading into any federal rescheduling update, as that geography may see the sharpest re-rating on positive policy news.
Thursday Catalyst Watch
Here is what Weedstock is tracking for Thursday, October 29:
- Tilray TLRY: Fiscal Q1 FY2027 earnings window — any pre-market release would move the tape at open.
- Federal regulatory calendar: DEA rescheduling proceedings continue in the background; any docket activity or court filings related to the cannabis rescheduling process could surface intraday headlines.
- State-level: Pennsylvania cannabis licensing board has a scheduled meeting Thursday — watch for any adult-use framework updates that could reprice MSOs with existing PA medical operations.
- Macro: U.S. GDP and jobless claims data Thursday pre-market. A risk-off session would weigh on speculative cannabis names; a risk-on tone would provide tailwinds, particularly for smaller-cap OTC tickers.
TL;DR
- CURLF drawing after-hours attention ahead of expected Q3 earnings update; thin OTC liquidity warrants caution.
- TLRY approaching fiscal Q1 FY2027 report — beverage segment margin and Canadian cannabis performance are the key watch items.
- Q3 earnings season broadly confirms: adult-use state exposure and cost discipline separate winners from laggards.
- Thursday brings Tilray earnings optionality, Pennsylvania licensing news, and macro data — set your alerts.
Track all cannabis tickers in real time on the Weedstock Cannabis Stock Tracker. Wednesday evening is always a good time to review your watchlist and position sizing before Thursday open.
Weedstock Market Intelligence is for informational purposes only and does not constitute investment advice. Cannabis stocks carry significant regulatory, liquidity, and volatility risk. Always conduct your own due diligence.